Exclusive Online Content
Catalent to Invest $5 Million at Somerset Site to Create New Drug Development & Modified Release Center of Excellence
Catalent Pharma Solutions recently announced it plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its…
Roquette: Bringing New Solutions for Biotherapeutics
Protein stabilization is a critical challenge facing biotherapeutic formulators due to a multitude of destabilizing forces and pathways. The complexity and natural propensity of proteins…
Noramco & SPI Pharma Sign Agreement to Develop Ready-to-Implement, Patient-Friendly Formulations
Noramco and SPI Pharma recently announced the two companies have signed an agreement to develop and license a set of “value-added” formulation packages for global…
WuXi AppTec Expands Site in the United States for Drug Development Testing Services
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, recently announced the opening of its expanded Laboratory Testing Division…
Provectus Biopharmaceuticals Expands Global Patent Portfolio
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company developing PV-10 as the first small molecule oncolytic immunotherapy for solid tumor cancers, recently announced that the Japan Patent…
Halo Pharma Simplifies Topical Drug Product Development & Manufacturing
Halo Pharma, a rapidly growing contract development and manufacturing organization (CDMO), offers more than 30 years’ direct experience in the production of topical drug products…
Argenx to Receive Third Preclinical Milestone Payment From LEO Pharma
argenx recently announced the achievement of its third preclinical milestone from its collaboration with LEO Pharma, following the approval of the clinical trial application (CTA)…
GSK Signs Strategic Agreement With Orchard Therapeutics
GSK and Orchard Therapeutics today announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to…
Stem Cell Technology Will Provide Revolutionary Treatments for Diseases
As stem cell technology has the ability to regenerate complex tissue of all types, it offers scope for revolutionary treatments for diseases that currently have…
TARA Scientific Co-Founders Grow Adult-Like Human Heart Tissue in Just 4 Weeks
TARA Biosystems Inc., a company offering physiologically relevant "heart-on-a-chip" tissue models for drug discovery and development applications, recently announced the publication of a landmark cardiac tissue…
EXCLUSIVE ONLINE CONTENT

Credence MedSystems Receives Strategic Investment From Novartis
Credence MedSystems recently announced that Novartis has made a strategic investment in the company. The investment will advance ongoing development and scaling of Credence’s innovative drug delivery systems….

Nexelis Acquires GSK Vaccines Clinical Bioanalytical Laboratory
Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, has signed an asset purchase agreement with GSK to….

ViGeneron Announces Research Collaboration With Daiichi Sankyo to Evaluate Novel Ophthalmic Gene Therapy
ViGeneron GmbH recently announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV) vectors with Daiichi Sankyo Company, Limited for delivering….

Molecular Templates Announces FDA Acceptance of IND Application for a PD-L1-Targeted Engineered Toxin Body Enabled With Proprietary Antigen Seeding Technology
Molecular Templates, Inc. recently announced the US FDA has accepted its Investigational New Drug (IND) application for MT-6402, a next-generation ETB targeting PD-L1 that is enabled with….

Clene Nanomedicine Receives Patent Notice of Allowance for using Gold Nanocrystals for Treating MS
Clene Inc. recently announced its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, was issued a Notice of Allowance from the US Patent and Trademark Office (USPTO) for its invention for….